Intracerebral hemorrhage after thrombolytic therapy in acute ischemic stroke patients with renal dysfunction

Tzu Hao Chao, Ting Chun Lin, Yao Shieh, Ting Yu Chang, Kuo Lun Hung, Chi Hung Liu, Tsong Hai Lee, Yeu Jhy Chang, Jiann Der Lee, Chien Hung Chang

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Purpose: One complication of thrombolysis is intracranial hemorrhage (ICH). We investigated whether treatment with tissue plasminogen activator (t-PA) for ischemic infarction results in a higher risk of ICH in patients with kidney dysfunction, who are predisposed to treatment complications due to their bleeding tendency. Methods: A total of 297 patients given thrombolytic therapy for ischemic stroke were classified into 2 groups on the basis of their estimated renal glomerular filtration rate (eGFR). The outcome measures included the incidence of ICH and modified Rankin scale scores at 1 month and 1 year. Results: ICH was more common in the renal dysfunction group (23 vs. 12.5%). Nevertheless, multivariate logistic regression showed that the odds of ICH were not high in the group with low eGFR. Also, eGFR values <60 ml/min/1.73 m 2 did not predict the odds for functional dependence or death at 1 month and 1 year. Conclusion: After adjusting for confounding factors, the odds ratio for ICH was not higher in intravenous t-PA-treated stroke patients with renal dysfunction. A trend to the occurrence of ICH among these patients, however, was noted. Renal dysfunction does not predict the odds for functional dependence or death at 1 month and 1 year.

Original languageEnglish
Pages (from-to)316-321
Number of pages6
JournalEuropean Neurology
Volume70
Issue number5-6
DOIs
Publication statusPublished - Jan 1 2013

Fingerprint

Intracranial Hemorrhages
Thrombolytic Therapy
Cerebral Hemorrhage
Stroke
Kidney
Glomerular Filtration Rate
Tissue Plasminogen Activator
Infarction
Logistic Models
Odds Ratio
Outcome Assessment (Health Care)
Hemorrhage
Incidence
Therapeutics

Keywords

  • Acute ischemic stroke
  • Intracerebral hemorrhage
  • Renal dysfunction
  • Thrombolytic therapy

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Intracerebral hemorrhage after thrombolytic therapy in acute ischemic stroke patients with renal dysfunction. / Chao, Tzu Hao; Lin, Ting Chun; Shieh, Yao; Chang, Ting Yu; Hung, Kuo Lun; Liu, Chi Hung; Lee, Tsong Hai; Chang, Yeu Jhy; Lee, Jiann Der; Chang, Chien Hung.

In: European Neurology, Vol. 70, No. 5-6, 01.01.2013, p. 316-321.

Research output: Contribution to journalArticle

Chao, TH, Lin, TC, Shieh, Y, Chang, TY, Hung, KL, Liu, CH, Lee, TH, Chang, YJ, Lee, JD & Chang, CH 2013, 'Intracerebral hemorrhage after thrombolytic therapy in acute ischemic stroke patients with renal dysfunction', European Neurology, vol. 70, no. 5-6, pp. 316-321. https://doi.org/10.1159/000353296
Chao, Tzu Hao ; Lin, Ting Chun ; Shieh, Yao ; Chang, Ting Yu ; Hung, Kuo Lun ; Liu, Chi Hung ; Lee, Tsong Hai ; Chang, Yeu Jhy ; Lee, Jiann Der ; Chang, Chien Hung. / Intracerebral hemorrhage after thrombolytic therapy in acute ischemic stroke patients with renal dysfunction. In: European Neurology. 2013 ; Vol. 70, No. 5-6. pp. 316-321.
@article{f6a5dd7d2335475da7d7dcd5542f1dbe,
title = "Intracerebral hemorrhage after thrombolytic therapy in acute ischemic stroke patients with renal dysfunction",
abstract = "Purpose: One complication of thrombolysis is intracranial hemorrhage (ICH). We investigated whether treatment with tissue plasminogen activator (t-PA) for ischemic infarction results in a higher risk of ICH in patients with kidney dysfunction, who are predisposed to treatment complications due to their bleeding tendency. Methods: A total of 297 patients given thrombolytic therapy for ischemic stroke were classified into 2 groups on the basis of their estimated renal glomerular filtration rate (eGFR). The outcome measures included the incidence of ICH and modified Rankin scale scores at 1 month and 1 year. Results: ICH was more common in the renal dysfunction group (23 vs. 12.5{\%}). Nevertheless, multivariate logistic regression showed that the odds of ICH were not high in the group with low eGFR. Also, eGFR values <60 ml/min/1.73 m 2 did not predict the odds for functional dependence or death at 1 month and 1 year. Conclusion: After adjusting for confounding factors, the odds ratio for ICH was not higher in intravenous t-PA-treated stroke patients with renal dysfunction. A trend to the occurrence of ICH among these patients, however, was noted. Renal dysfunction does not predict the odds for functional dependence or death at 1 month and 1 year.",
keywords = "Acute ischemic stroke, Intracerebral hemorrhage, Renal dysfunction, Thrombolytic therapy",
author = "Chao, {Tzu Hao} and Lin, {Ting Chun} and Yao Shieh and Chang, {Ting Yu} and Hung, {Kuo Lun} and Liu, {Chi Hung} and Lee, {Tsong Hai} and Chang, {Yeu Jhy} and Lee, {Jiann Der} and Chang, {Chien Hung}",
year = "2013",
month = "1",
day = "1",
doi = "10.1159/000353296",
language = "English",
volume = "70",
pages = "316--321",
journal = "European Neurology",
issn = "0014-3022",
publisher = "S. Karger AG",
number = "5-6",

}

TY - JOUR

T1 - Intracerebral hemorrhage after thrombolytic therapy in acute ischemic stroke patients with renal dysfunction

AU - Chao, Tzu Hao

AU - Lin, Ting Chun

AU - Shieh, Yao

AU - Chang, Ting Yu

AU - Hung, Kuo Lun

AU - Liu, Chi Hung

AU - Lee, Tsong Hai

AU - Chang, Yeu Jhy

AU - Lee, Jiann Der

AU - Chang, Chien Hung

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Purpose: One complication of thrombolysis is intracranial hemorrhage (ICH). We investigated whether treatment with tissue plasminogen activator (t-PA) for ischemic infarction results in a higher risk of ICH in patients with kidney dysfunction, who are predisposed to treatment complications due to their bleeding tendency. Methods: A total of 297 patients given thrombolytic therapy for ischemic stroke were classified into 2 groups on the basis of their estimated renal glomerular filtration rate (eGFR). The outcome measures included the incidence of ICH and modified Rankin scale scores at 1 month and 1 year. Results: ICH was more common in the renal dysfunction group (23 vs. 12.5%). Nevertheless, multivariate logistic regression showed that the odds of ICH were not high in the group with low eGFR. Also, eGFR values <60 ml/min/1.73 m 2 did not predict the odds for functional dependence or death at 1 month and 1 year. Conclusion: After adjusting for confounding factors, the odds ratio for ICH was not higher in intravenous t-PA-treated stroke patients with renal dysfunction. A trend to the occurrence of ICH among these patients, however, was noted. Renal dysfunction does not predict the odds for functional dependence or death at 1 month and 1 year.

AB - Purpose: One complication of thrombolysis is intracranial hemorrhage (ICH). We investigated whether treatment with tissue plasminogen activator (t-PA) for ischemic infarction results in a higher risk of ICH in patients with kidney dysfunction, who are predisposed to treatment complications due to their bleeding tendency. Methods: A total of 297 patients given thrombolytic therapy for ischemic stroke were classified into 2 groups on the basis of their estimated renal glomerular filtration rate (eGFR). The outcome measures included the incidence of ICH and modified Rankin scale scores at 1 month and 1 year. Results: ICH was more common in the renal dysfunction group (23 vs. 12.5%). Nevertheless, multivariate logistic regression showed that the odds of ICH were not high in the group with low eGFR. Also, eGFR values <60 ml/min/1.73 m 2 did not predict the odds for functional dependence or death at 1 month and 1 year. Conclusion: After adjusting for confounding factors, the odds ratio for ICH was not higher in intravenous t-PA-treated stroke patients with renal dysfunction. A trend to the occurrence of ICH among these patients, however, was noted. Renal dysfunction does not predict the odds for functional dependence or death at 1 month and 1 year.

KW - Acute ischemic stroke

KW - Intracerebral hemorrhage

KW - Renal dysfunction

KW - Thrombolytic therapy

UR - http://www.scopus.com/inward/record.url?scp=84890498017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890498017&partnerID=8YFLogxK

U2 - 10.1159/000353296

DO - 10.1159/000353296

M3 - Article

C2 - 24080988

AN - SCOPUS:84890498017

VL - 70

SP - 316

EP - 321

JO - European Neurology

JF - European Neurology

SN - 0014-3022

IS - 5-6

ER -